Impact of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation.

[1]  T. Cotter,et al.  Nonalcoholic Fatty Liver Disease 2020: The State of the Disease , 2020 .

[2]  T. Cotter,et al.  Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system , 2020, Journal of Gastroenterology.

[3]  T. Cotter,et al.  NAFLD 2020: The State of the Disease. , 2020, Gastroenterology.

[4]  P. Schauer,et al.  Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  W. Saliba,et al.  Association Between Pre-Ablation Glycemic Control and Outcomes Among Patients With Diabetes Undergoing Atrial Fibrillation Ablation. , 2019, JACC. Clinical electrophysiology.

[6]  J. Brugada,et al.  Impact of body mass index on the outcome of catheter ablation of atrial fibrillation , 2018, Heart.

[7]  Chengfu Xu,et al.  Nonalcoholic Fatty Liver Disease Is Associated with Increased Atrial Fibrillation Risk in an Elderly Chinese Population: A Cross-Sectional Study , 2018, BioMed research international.

[8]  R. Mahajan,et al.  PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[10]  R. Hultcrantz,et al.  Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. , 2017, Journal of hepatology.

[11]  S. Ernst,et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  J. B. Moore,et al.  Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review , 2017, Proceedings of the Nutrition Society.

[13]  Z. Goodman,et al.  Epidemiology and natural history of non-alcoholic fatty liver disease. , 2016, Metabolism: clinical and experimental.

[14]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[15]  R. Stauber,et al.  EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects , 2016, Diabetologia.

[16]  H. Huikuri,et al.  Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study) , 2015, PloS one.

[17]  Christopher X. Wong,et al.  Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). , 2015, Journal of the American College of Cardiology.

[18]  A. Toor,et al.  Total Body Weight Loss of ≥10 % Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis , 2015, Digestive Diseases and Sciences.

[19]  R. Mahajan,et al.  Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. , 2014, Journal of the American College of Cardiology.

[20]  Randall C. Thompson,et al.  Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals. , 2013, Mayo Clinic proceedings.

[21]  C. Hung,et al.  Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate Variability , 2013, PloS one.

[22]  Sombat Treeprasertsuk,et al.  NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. , 2013, World journal of gastroenterology.

[23]  L. Di Biase,et al.  Reply: To PMID 22464257. , 2013, Journal of the American College of Cardiology.

[24]  G. Musso,et al.  Obstructive Sleep Apnea–Hypopnea Syndrome and Nonalcoholic Fatty Liver Disease: Emerging Evidence and Mechanisms , 2012, Seminars in Liver Disease.

[25]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  K. Filion,et al.  Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. , 2011, The American journal of cardiology.

[27]  Chiadi E. Ndumele,et al.  Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Enzo Bonora,et al.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[29]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[30]  S. Goland,et al.  Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment , 2006, Journal of clinical gastroenterology.

[31]  K. Batts,et al.  Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.

[32]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[33]  G. MacGowan,et al.  Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. , 2012, Journal of hepatology.

[34]  C. Day,et al.  Non-alcoholic fatty liver disease: the mist gradually clears. , 2008, Journal of hepatology.

[35]  D. Parish,et al.  Obesity and the risk of new-onset atrial fibrillation. , 2005, JAMA.